NDC 66794-228

Rocuronium

Rocuronium

Rocuronium is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Piramal Critical Care Inc. The primary component is Rocuronium Bromide.

Product ID66794-228_98255b70-51fa-8d16-e053-2995a90a8f97
NDC66794-228
Product TypeHuman Prescription Drug
Proprietary NameRocuronium
Generic NameRocuronium
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-06-01
Marketing CategoryANDA / ANDA
Application NumberANDA210437
Labeler NamePiramal Critical Care Inc
Substance NameROCURONIUM BROMIDE
Active Ingredient Strength50 mg/5mL
Pharm ClassesNeuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 66794-228-41

10 VIAL in 1 CARTON (66794-228-41) > 5 mL in 1 VIAL (66794-228-02)
Marketing Start Date2020-07-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66794-228-02 [66794022802]

Rocuronium INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA210437
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-01

NDC 66794-228-41 [66794022841]

Rocuronium INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA210437
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-01

Drug Details

NDC Crossover Matching brand name "Rocuronium" or generic name "Rocuronium"

NDCBrand NameGeneric Name
63323-426RocuroniumROCURONIUM BROMIDE
65219-065RocuroniumROCURONIUM BROMIDE
65293-426RocuroniumROCURONIUM BROMIDE
65293-427RocuroniumROCURONIUM BROMIDE
66794-228RocuroniumRocuronium
66794-229RocuroniumRocuronium
81565-204RocuroniumROCURONIUM BROMIDE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.